Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.FDA grants orphan drug status to AstraZeneca cancer drug
The drug has received the designation as it has potential to treat a disorder that affects less than 200,000 people in the US. The status confers several benefits
The drug has received the designation as it has potential to treat a disorder that affects less than 200,000 people in the US. The status confers several benefits
The FDA grants priority review status to products that are considered to be potentially significant therapeutic advancements over existing approved therapies in the treatment, diagnosis or prevention of
The companies have signed separate royalty free license agreements with the International Partnership for Microbicides (IPM) that will allow the organization to develop the compounds as vaginal gels
The trial, which involved nearly 300 patients, was aimed at evaluating the safety and efficacy of locally administered 17beta-estradiol, the most potent estrogen. The study monitored its ability
The finding may support cheek cell analysis as a simple and inexpensive early screening method for patients at risk of the disease. The company analyzed randomized cheek scrapings
The drug will be studied in combination with radiologic therapy, and other drugs and biologics in the treatment of solid tumors including esophageal, gastric and pancreatic cancers. The
The research, presented this week at the annual meeting of the American College of Gastroenterology, found that a significantly higher proportion of patients who responded to an induction
A total of 50 patients are to be entered into the trial, which will be conducted in Singapore, Malaysia and Vietnam. The study, which was designed in collaboration
The application seeks approval for use of Erbitux in combination with radiation for locally or regionally advanced head and neck cancer, and as monotherapy in patients with recurrent
The chemically synthesized adjuvant will be tested by Sanofi Pasteur to determine its ability to enhance the immune response to a broad range of vaccines. Under the terms